News
When it comes to cutting-edge health technology, Jecizer Biosciences is quickly becoming the name you’ve probably haven’t ...
BIO, a key biotech lobby group, labels RFK Jr. a public health threat amid vaccine skepticism. Read more here.
If you’re using ChatGPT but getting mediocre results, don’t blame the chatbot. Instead, try sharpening up your prompts.
3d
Stocktwits on MSNAbbVie To Acquire Capstan Therapeutics For Up To $2.1 Billion To Boost Immunology Portfolio As Humira Sales Drop: Stock Gains In Morning TradeAbbVie (ABBV) on Monday announced that it has entered into a definitive agreement to acquire privately held clinical-stage ...
Explore how agrivoltaics is transforming India’s agriculture by integrating solar energy with farming to boost crop yields ...
22hOpinion
The National Interest on MSNSouth Korea Desperately Needs a New Foreign PolicyAmid rising global power politics, South Korea's new Lee Jae-myung administration must strengthen national self-reliance in ...
European startups have long struggled to scale at home, but a new EU strategy could finally position the continent as a ...
Learning from increased cases of litigation and the existing model of extensive land use for non-agricultural purposes, ...
The quest for longevity has captivated humanity since the dawn of civilization—from ancient Egyptian mummification rituals ...
European STOXX Europe 600 Index rising as geopolitical tensions eased and economic stimulus measures were announced. Amidst this backdrop, investors might find opportunities in penny stocks—an ...
Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the pricing of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results